Real-world longitudinal assessment of anifrolumab in patients with systemic lupus erythematosus: clinical outcomes, safety and modulation of cytokines and neutrophil activitySelahattin Alp Temiz, Filippo Fagni, Janina Schoen et al.|RMD Open|2026Cited by 0